CytoSorbents Corporation Reverse Stock Split

CytoSorbents Corporation announced a one-for-twenty reverse stock split of its common stock, effective September 8, 2026. This action, approved by shareholders, reduces the number of outstanding shares from 63,022,020 to approximately 3,151,101. The par value per share remains $0.001. The reverse stock split also proportionately adjusts outstanding options and warrants. Fractional shares resulting from the split will be rounded up to the nearest whole share. Trading on the Nasdaq will continue on a split-adjusted basis, with a new CUSIP number 23283X305. The company has filed a certificate of amendment to its Certificate of Incorporation to effect this change. No shareholder action is required for those holding shares in book-entry or street name.